Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms

Clin Biochem. 2010 Mar;43(4-5):407-10. doi: 10.1016/j.clinbiochem.2009.11.006. Epub 2009 Nov 22.

Abstract

Objectives: Apolipoproteins play important roles in the development of atherosclerosis but their involvement in the pathogenesis of abdominal aortic aneurysm (AAA) is poorly understood. The aim was to investigate whether apoA-I, apoB and apoM are independently associated with AAA.

Design and methods: Plasma apoA-I, apoB and apoM were measured in 343 patients with AAA and in 214 elderly apparently healthy control individuals from the background population.

Results: AAA patients had lower apolipoprotein levels, as compared to healthy individuals: apoA-I, 1.62 vs. 2.08 g/L; apoB, 0.91 vs. 1.04 g/L; apoM, 0.72 vs. 0.91 mumol/L (p<0.0001 for all three). In multivariate analyses, apoA-I and apoB were associated with AAA, odds ratios (95% confidence intervals) being 0.53 (0.43-0.64) and 0.86 (0.75-0.998), respectively.

Conclusions: ApoA-I, apoB and apoM levels were significantly lower in patients with AAA than in the control individuals, but only apoA-I and apoB were independently associated to AAA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aortic Aneurysm, Abdominal / blood*
  • Aortic Aneurysm, Abdominal / drug therapy
  • Apolipoprotein A-I / blood*
  • Apolipoproteins / blood*
  • Apolipoproteins B / blood*
  • Apolipoproteins M
  • Case-Control Studies
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Lipocalins
  • Logistic Models
  • Male
  • Multivariate Analysis

Substances

  • APOM protein, human
  • Apolipoprotein A-I
  • Apolipoproteins
  • Apolipoproteins B
  • Apolipoproteins M
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipocalins